Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FNJZH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,379
Award facts
- Contract value 100% obligated
- $11,379.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,379.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COSENTYX (secukinumab) 300mg dose in 2 pen/mL formulation, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a direct procurement action issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The company, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for federal military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's broader pharmaceutical supply mission supporting DLA's medical supply chain operations. COSENTYX is a biologic immunosuppressant used to treat various autoimmune conditions, and its procurement through the SPE2DX vehicle reflects the Defense Health Agency's need to maintain consistent access to specialized medications for active duty service members, retirees, and dependents. The award continues AmerisourceBergen's established role as a critical vendor in the Pharmaceutical Prime Vendor program, which enables flexible sourcing of a comprehensive range of brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DB25FNJZH?
SPE2DB25FNJZH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FNJZH worth?
The government has obligated $11,379 on SPE2DB25FNJZH.
Is contract SPE2DB25FNJZH an order under another contract?
Yes. SPE2DB25FNJZH is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNJZH competed?
The extent of competition for SPE2DB25FNJZH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award